416 related articles for article (PubMed ID: 36181610)
1. Cardio-Oncology in Childhood: State of the Art.
Bennati E; Girolami F; Spaziani G; Calabri GB; Favre C; Parrini I; Lucà F; Tamburini A; Favilli S
Curr Oncol Rep; 2022 Dec; 24(12):1765-1777. PubMed ID: 36181610
[TBL] [Abstract][Full Text] [Related]
2. Strategies to Prevent Cardiotoxicity.
Graffagnino J; Kondapalli L; Arora G; Hawi R; Lenneman CG
Curr Treat Options Oncol; 2020 Apr; 21(4):32. PubMed ID: 32270293
[TBL] [Abstract][Full Text] [Related]
3. Novel approaches to the prediction, diagnosis and treatment of cardiac late effects in survivors of childhood cancer: a multi-centre observational study.
Skitch A; Mital S; Mertens L; Liu P; Kantor P; Grosse-Wortmann L; Manlhiot C; Greenberg M; Nathan PC
BMC Cancer; 2017 Aug; 17(1):519. PubMed ID: 28774277
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy-induced cardiotoxicity in children.
Bansal N; Amdani S; Lipshultz ER; Lipshultz SE
Expert Opin Drug Metab Toxicol; 2017 Aug; 13(8):817-832. PubMed ID: 28679288
[TBL] [Abstract][Full Text] [Related]
5. Cardiac complications in childhood cancer survivors treated with anthracyclines.
Franco VI; Lipshultz SE
Cardiol Young; 2015 Aug; 25 Suppl 2():107-16. PubMed ID: 26377717
[TBL] [Abstract][Full Text] [Related]
6. Cardio-oncology for Pediatric and Adolescent/Young Adult Patients.
Tolani D; Wilcox J; Shyam S; Bansal N
Curr Treat Options Oncol; 2023 Aug; 24(8):1052-1070. PubMed ID: 37296365
[TBL] [Abstract][Full Text] [Related]
7. Managing chemotherapy-related cardiotoxicity in survivors of childhood cancers.
Lipshultz SE; Diamond MB; Franco VI; Aggarwal S; Leger K; Santos MV; Sallan SE; Chow EJ
Paediatr Drugs; 2014 Oct; 16(5):373-89. PubMed ID: 25134924
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular Toxicities in Pediatric Cancer Survivors.
Ryan TD; Nagarajan R; Godown J
Cardiol Clin; 2019 Nov; 37(4):533-544. PubMed ID: 31587793
[TBL] [Abstract][Full Text] [Related]
9. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management.
Curigliano G; Cardinale D; Dent S; Criscitiello C; Aseyev O; Lenihan D; Cipolla CM
CA Cancer J Clin; 2016 Jul; 66(4):309-25. PubMed ID: 26919165
[TBL] [Abstract][Full Text] [Related]
10. Cardiotoxicity among adult survivors suffered from childhood malignancies.
Petropoulos AC; Moschovi M
Hell J Nucl Med; 2019; 22 Suppl 2():34-40. PubMed ID: 31802042
[TBL] [Abstract][Full Text] [Related]
11. Cardio-oncology: a multidisciplinary approach for detection, prevention and management of cardiac dysfunction in cancer patients.
Tajiri K; Aonuma K; Sekine I
Jpn J Clin Oncol; 2017 Aug; 47(8):678-682. PubMed ID: 28505345
[TBL] [Abstract][Full Text] [Related]
12. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.
Cheuk DK; Sieswerda E; van Dalen EC; Postma A; Kremer LC
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD008011. PubMed ID: 27552363
[TBL] [Abstract][Full Text] [Related]
13. Cardio-oncology, the myth of Sisyphus, and cardiovascular disease in breast cancer survivors.
Mavrogeni SI; Sfendouraki E; Markousis-Mavrogenis G; Rigopoulos A; Noutsias M; Kolovou G; Angeli C; Tousoulis D
Heart Fail Rev; 2019 Nov; 24(6):977-987. PubMed ID: 31134427
[TBL] [Abstract][Full Text] [Related]
14. Cardio-oncology: Shared Genetic, Metabolic, and Pharmacologic Mechanism.
Zhao Y; Jia H; Hua X; An T; Song J
Curr Cardiol Rep; 2023 Aug; 25(8):863-878. PubMed ID: 37493874
[TBL] [Abstract][Full Text] [Related]
15. Age-Related Considerations in Cardio-Oncology.
Screever EM; Meijers WC; Moslehi JJ
J Cardiovasc Pharmacol Ther; 2021 Mar; 26(2):103-113. PubMed ID: 33124480
[TBL] [Abstract][Full Text] [Related]
16. Heartbreaker: Detection and prevention of cardiotoxicity in hematological malignancies.
Vakilpour A; Lefebvre B; Lai C; Scherrer-Crosbie M
Blood Rev; 2024 Mar; 64():101166. PubMed ID: 38182490
[TBL] [Abstract][Full Text] [Related]
17. Genetic factors in anthracycline-induced cardiotoxicity in patients treated for pediatric cancer.
Petrykey K; Andelfinger GU; Laverdière C; Sinnett D; Krajinovic M
Expert Opin Drug Metab Toxicol; 2020 Oct; 16(10):865-883. PubMed ID: 32772754
[TBL] [Abstract][Full Text] [Related]
18. Late-onset cardiomyopathy among survivors of childhood lymphoma treated with anthracyclines: a systematic review.
Benetou DR; Stergianos E; Geropeppa M; Ntinopoulou E; Tzanni M; Pourtsidis A; Petropoulos AC; Georgakis MK; Tousoulis D; Petridou ET
Hellenic J Cardiol; 2019; 60(3):152-164. PubMed ID: 30273645
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy-induced cardiomyopathy.
Higgins AY; O'Halloran TD; Chang JD
Heart Fail Rev; 2015 Nov; 20(6):721-30. PubMed ID: 26338137
[TBL] [Abstract][Full Text] [Related]
20. Modeling Precision Cardio-Oncology: Using Human-Induced Pluripotent Stem Cells for Risk Stratification and Prevention.
Perry TR; Roberts ML; Sunkara B; Maddula R; McLeish T; Gomez J; Lucas J; Rayan D; Patel S; Liang M; Bosnjak ZJ; Brown SA
Curr Oncol Rep; 2021 May; 23(7):77. PubMed ID: 33937943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
